SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SALVADORI, Severo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.744
AS - Asia 11.406
EU - Europa 6.177
SA - Sud America 1.675
AF - Africa 241
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
Totale 43.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.361
SG - Singapore 4.213
CN - Cina 3.061
UA - Ucraina 1.316
DE - Germania 1.298
BR - Brasile 1.297
VN - Vietnam 1.133
HK - Hong Kong 1.007
TR - Turchia 884
GB - Regno Unito 788
IT - Italia 745
FI - Finlandia 513
FR - Francia 407
SE - Svezia 359
RU - Federazione Russa 280
JP - Giappone 218
IN - India 205
MX - Messico 169
CA - Canada 165
BD - Bangladesh 130
AR - Argentina 122
PL - Polonia 114
ZA - Sudafrica 89
IQ - Iraq 79
BE - Belgio 78
ID - Indonesia 78
CO - Colombia 67
PK - Pakistan 63
NL - Olanda 60
EC - Ecuador 54
ES - Italia 51
UZ - Uzbekistan 47
PH - Filippine 44
VE - Venezuela 37
SA - Arabia Saudita 35
LT - Lituania 33
MA - Marocco 32
CL - Cile 30
TN - Tunisia 30
AT - Austria 24
MY - Malesia 24
AE - Emirati Arabi Uniti 23
PY - Paraguay 22
IR - Iran 21
KR - Corea 21
EG - Egitto 20
KE - Kenya 20
PE - Perù 18
CZ - Repubblica Ceca 17
JO - Giordania 17
UY - Uruguay 17
IL - Israele 16
DZ - Algeria 13
RO - Romania 13
AU - Australia 12
AL - Albania 11
CH - Svizzera 11
NP - Nepal 11
BO - Bolivia 10
ET - Etiopia 9
LB - Libano 9
BH - Bahrain 8
HN - Honduras 8
JM - Giamaica 8
AZ - Azerbaigian 7
IE - Irlanda 7
PA - Panama 7
TH - Thailandia 7
NZ - Nuova Zelanda 6
SN - Senegal 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
EU - Europa 5
HR - Croazia 5
KZ - Kazakistan 5
OM - Oman 5
QA - Qatar 5
DK - Danimarca 4
GR - Grecia 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
PS - Palestinian Territory 4
PT - Portogallo 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BJ - Benin 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
LV - Lettonia 3
MM - Myanmar 3
MT - Malta 3
NG - Nigeria 3
NI - Nicaragua 3
NO - Norvegia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
Totale 43.228
Salva come PNG Salva come JPEG
Città #
Singapore 2.679
Ashburn 2.398
Fairfield 2.364
Woodbridge 2.349
Houston 1.589
Jacksonville 1.432
Ann Arbor 1.248
San Jose 1.242
Chandler 1.102
Hong Kong 994
Beijing 965
Seattle 913
Santa Clara 901
Wilmington 847
Cambridge 789
Izmir 441
Nanjing 415
Ho Chi Minh City 372
Dallas 353
Munich 310
Los Angeles 301
Princeton 276
Hanoi 258
New York 236
San Diego 235
Lauterbourg 229
Tokyo 216
Boardman 196
Dearborn 196
Milan 189
Helsinki 169
Ferrara 152
São Paulo 128
Nanchang 122
Falkenstein 117
Shenyang 116
Hefei 110
Shanghai 105
Warsaw 104
Mexico City 102
Addison 89
London 83
Falls Church 81
Orem 78
Turku 78
San Mateo 75
Brussels 73
Hebei 72
Tianjin 72
Brooklyn 70
Auburn Hills 65
Bremen 63
Jiaxing 63
Jinan 63
Changsha 62
Chicago 60
Haiphong 57
Frankfurt am Main 55
Buffalo 52
Da Nang 51
Mountain View 49
The Dalles 48
Kunming 47
Montreal 47
Moscow 46
Denver 45
Johannesburg 45
San Francisco 45
Toronto 45
Stockholm 43
Atlanta 42
Redwood City 41
Tashkent 41
Washington 41
Chennai 40
Philadelphia 39
Rio de Janeiro 39
Zhengzhou 39
Council Bluffs 38
Phoenix 38
Poplar 38
Guangzhou 36
Ningbo 35
Norwalk 35
Belo Horizonte 33
Boston 33
Manchester 33
Baghdad 29
Hải Dương 29
Bologna 28
Columbus 28
Dhaka 26
Biên Hòa 25
Medellín 25
Jakarta 24
Mumbai 24
Tappahannock 24
Curitiba 23
Des Moines 22
Mcallen 22
Totale 30.052
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 392
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 336
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 326
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 291
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 287
A cyclic peptide T analogue with high chemotactic activity 285
A new selective antagonist of the nociceptin receptor 269
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 269
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 260
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 257
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 253
A new ligand for the urotensin II receptor 252
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 243
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 241
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 240
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 238
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 237
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 236
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 235
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 235
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 232
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 231
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 231
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 231
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 230
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 228
Dermorphin inhibits spinal nociceptive flexion reflex in humans 227
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 226
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 226
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 222
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 218
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 218
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 217
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 216
Pharmacological characterization of tachykinin tetrabranched derivatives 214
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 211
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 211
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 211
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 210
Physicochemical stability of cabazitaxel and docetaxel solutions 210
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 208
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 206
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 206
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 205
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 202
Neuropeptide S receptor ligands: a patent review (2005-2016) 202
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 200
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 198
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 198
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 198
Pharmacological characterization of nociceptin receptor: an in vitro study 198
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 196
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 196
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 196
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 195
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 195
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 194
Structure-activity study at positions 3 and 4 of human neuropeptide S. 194
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 194
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 194
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 194
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 194
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 193
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 189
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 188
Dermorphin decreases plasma LH levels in human: Evidence for a modulatory role of gonadal steroids 188
Critical role for prokineticin 2 in CNS autoimmunity 187
Design of d-opioid peptide antagonists for emerging drug applications 187
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 185
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 185
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 183
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 183
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 181
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 181
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 180
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 180
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 180
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 179
Structure–activity relationships of cyclic and linear peptide T analogues 179
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 179
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 177
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 176
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 176
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 176
Structure-activity relationship study on human urotensin II 175
Synthesis and biological activity of carboxyl terminally extended dermorphins 173
Nociceptin/orphanin FQ receptor ligands 173
Somatostatin Inhibits the Dermorphin-Stimulated Thyrotropin Release in Man 172
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 172
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 172
6-N,N-dimethylamino-2,3-naphthalimide: A new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides 171
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 169
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 169
SUPRAMOLECULAR AGGREGATES COMPRISING MALEIMIDO CORES 169
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 168
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 168
In vitro and in vivo pharmacological profile of UFP-512, a novel selective δ-opioid receptor agonist; correlations between desensitization and tolerance 168
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 168
Characterization of N,N(Me)(2)-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist 167
Totale 20.937
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.220
Totale 189.065
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 0 0 0 0 0 470 171
2021/20222.994 126 290 230 211 230 135 136 170 114 228 224 900
2022/20232.733 297 96 90 335 463 380 148 272 388 16 143 105
2023/20241.291 150 183 94 32 103 233 51 82 17 22 32 292
2024/20255.005 141 106 410 141 637 458 156 346 682 512 749 667
2025/202614.233 1.509 666 1.429 2.046 2.032 995 1.674 739 1.380 1.686 77 0
Totale 43.535